Yusuke Joki

Tokyo, 1138431, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Parathyroid Hormone Contributes to Pulmonary Hypertension in Hypoxic Conditions.

Parathyroid Hormone Contributes to Pulmonary Hypertension in Hypoxic Conditions.

Journal: Circulation research
Published: March 04, 2026

Natural senolytic activity of Rhodiola rosea extract alleviates age-associated phenotypes via paraptosis.

Natural senolytic activity of Rhodiola rosea extract alleviates age-associated phenotypes via paraptosis.

Journal: iScience
Published: October 31, 2025

Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.

Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.

Journal: Respiratory investigation
Published: June 19, 2023

SGLT2 inhibition eliminates senescent cells and alleviates pathological aging.

SGLT2 inhibition eliminates senescent cells and alleviates pathological aging.

Journal: Nature aging
Published: May 11, 2023

Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.

Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.

Journal: Journal of cardiology
Published: June 17, 2022

Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.

Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.

Journal: Respirology (Carlton, Vic.)
Published: September 28, 2021

Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.

Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.

Journal: PloS one
Published: August 24, 2021

Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury.

Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury.

Journal: Circulation research
Published: December 20, 2018

Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents.

Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents.

Journal: PloS one
Published: December 03, 2018

Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.

Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.

Journal: Circulation. Heart failure
Published: February 07, 2015

FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.

FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.

Journal: Biochemical and biophysical research communications
Published: February 05, 2015

Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Journal: Journal of the American Society of Nephrology : JASN
Published: July 30, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026